vimarsana.com


Using nanobodies to block a tick-borne bacterial infection
Tiny molecules called nanobodies, which can be designed to mimic antibody structures and functions, may be the key to blocking a tick-borne bacterial infection that remains out of reach of almost all antibiotics, new research suggests.
The infection is called human monocytic ehrlichiosis, and is one of the most prevalent and potentially life-threatening tick-borne diseases in the United States. The disease initially causes flu-like symptoms common to many illnesses, and in rare cases can be fatal if left untreated.
Most antibiotics can’t build up in high enough concentrations to kill the infection-causing bacteria, 

Related Keywords

Ohio ,United States ,Ohio State University ,Mingqun Lin ,Hongyan Liu ,Khemraj Budachetri ,Ashweta Sahni ,Dehua Pei ,Jeffrey Lakritz ,Libo Hou ,Qi Yan ,Yasuko Rikihisa ,Wenqing Zhang ,Ching Han ,Proceedings Of The National Academy Sciences ,National Institutes Of Health ,State University ,National Academy ,Ohio State ,National Institutes ,ஓஹியோ ,ஒன்றுபட்டது மாநிலங்களில் ,ஓஹியோ நிலை பல்கலைக்கழகம் ,ஜெஃப்ரி லக்ரிட்ஸ் ,குய் யான் ,தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் ,நிலை பல்கலைக்கழகம் ,தேசிய கலைக்கழகம் ,ஓஹியோ நிலை ,தேசிய நிறுவனங்கள் ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.